Weeks after a Cane Bay couple were taken into custody, charged with more than a dozen counts each on animal abuse-related ...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced results from the pivotal Phase 3 ENERGY 3 trial evaluating BMN 401 in children aged 1-12 with ENPP1 deficiency, a rare, serious and ...

Knock knees, also called genu valgum, are a common part of early childhood development in which the knees angle inward and ...

The trial showed that BMN 401 increased plasma PPi levels through week 52 versus the control group.

BioMarin shares fall after BMN 401 meets a biomarker goal but misses a key radiographic endpoint in a late-stage ENPP1 deficiency study.

Vitamin D isn’t just for strong bones – it also helps regulate your immune system and prevent infections ...

ENERGY 3 study met 1 of 2 co-primary endpoints in children with ENPP1 deficiency Treatment with BMN 401 led to statistically significant increases in plasma inorganic ...

BioMarin Pharmaceutical said on Monday its experimental treatment for a rare genetic condition met one of the two main goals ​in a late-stage study. The company was testing its enzyme ‌replacement ...

See how a daily vitamin D habit supports bone health and immune function if you are deficient.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best low priced stocks to buy for the next 3 years. On May 18, ...

A man who was bullied at school fought back to become a hairstylist to the stars – including Ariana Grande. Carl Bembridge, 35 , was a “shy” schoolboy and underwent eleven operations for bone ...